Inspire Veterinary Partners raises up to $10M via Series B convertible preferred stock

INSPIRE VETERINARY PARTNERS, INC.

First closing generated ~$5M in cash and transferred securities; up to $4M additional at investor option.
Series B Preferred has $1,000 stated value, convertible at $1.00 per share; warrants exercisable at $1.00.
Company also entered a common stock purchase agreement for up to $50M at a floor price of $0.75.
Proceeds to fund working capital, acquisitions, and address Nasdaq shareholders' equity deficiency.
Certificate of Designations for Series B filed; stockholder approval sought for below-price conversion adjustments.

Key facts

Extracted from this filing and checked against the source text.

Governance Changes SEC 8-K Item 5.03/5.05/5.06 confidence 0.9

INSPIRE VETERINARY PARTNERS, INC.: Filed Certificate of Designations establishing Series B Preferred Stock (effective 2025-07-29).

Change: charter amendment
Effective: 2025-07-29

Exact text from the filing

On July 28, 2025, the Company filed the Certificate of Designations for the purpose of designating and establishing the Company’s Series B Preferred Stock. The Certificate of Designations was filed pursuant to the Securities Purchase Agreement. The Certificate of Designations became effective on July 29, 2025.

View on SEC.gov

23 governance changes filed in the last 30 days. Browse all governance changes →

INSPIRE VETERINARY PARTNERS, INC. filing history →

Source: SEC EDGAR

accession 0001213900-25-070932

view filing index on sec.gov

view primary document

Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.